Skip to main contentAI and Advanced
/
3BBLACKBIO · NSEBSE SENSEX77,537.72+0.82%BSE |
NIFTY 5024,231.85+0.64%NSE |
NIFTY BANK57,495.9+0.45%NSE |
NIFTY IT30,673.05+0.79%NSE |
NIFTY AUTO29,301.75+0.40%NSE |
NIFTY FMCG47,863.25+0.82%NSE |
NIFTY PHARMA26,416+0.39%NSE |
NIFTY 50023,512.95+0.54%NSE |
3B
NSE · Equity shares · Chemical Manufacturing12.10 · 1.06%
3B Blackbio DX 3BBLACKBIO
NSE:INR 1,159
BSE:INR 1,278
Data quality and coveragePrice, company fundamentals and optional research feeds are tracked separately.
Headline priceLast market snapshot
Company fundamentalsStale · last-known data
Research sections9 of 9 availableMissing source values remain unavailable, never zero-filled.
AI analysis and Advanced tools for 3BBLACKBIO
Analysis, reports, chat and Advanced access use the same ShareKeyX account. The backend remains authoritative for roles, subscriptions, credits and permissions.
Snapshot
Price and key statistics
Reported and computed values remain separate; missing values are not converted to zero.
Previous closeINR 1,146.9
Day rangeINR 1,099.5 — INR 1,178
52-week rangeINR 1,085 — INR 1,441.5
Volume21,991
Market cap1,107.88
P/E18.19
Fundamental highlightsReported values unless marked as computed
Revenue (INR Cr)141.92
Net Income (INR Cr)58.59
Rev Growth (5 Year %)-8.95
EPS Growth (5 Year %)-14.38
P/E Ratio18.19
Book Value377.95
EPS69.94
Price/BV3.07Computed
Research path: Interpret 3B Blackbio DX's snapshot alongside the wider market dashboard, the financial-statement research guide and the valuation-ratios field guide.
Validated OHLC
Interactive price chart
Crosshair, OHLCV tooltip, indicators, volume, zoom and pan use the same candle API as the advanced workspace.
3BBLACKBIO3B Blackbio DX1d · INR · NSE
Loading validated candles…
Auditable calculations
Daily technical summary
Calculated from validated daily candles. Descriptive research only.
Calculating technicals…
Indicators describe price behaviour and volatility; they are not a BUY, NEUTRAL or SELL recommendation.
Company reporting
Financial statements
IND AS · INR crore
| Metric | 2026 | 2025 | 2024 |
|---|---|---|---|
| Total Liabilities Shareholders' Equity | 378 | 295.72 | 248.1 |
| Cash Equivalents | 38.31 | 12.47 | 13.62 |
| Other Liabilities Total | 0 | 0 | 0 |
| Long Term Debt | 3.11 | 0.31 | 0.79 |
| Common Stock Total | 8.57 | 8.57 | 8.57 |
| Other Current Assets Total | 23.37 | 0 | 16.44 |
| Total Assets | 378 | 295.72 | 248.1 |
| Cash | 62.31 | 56.36 | 48.53 |
| Total Equity | 324.38 | 268.42 | 223.05 |
| Long Term Investments | 157.7 | 156.31 | 117.31 |
| Retained Earnings(Accumulated Deficit) | 315.81 | 259.85 | 214.48 |
| Total Common Shares Outstanding | 0.86 | 0.86 | 0.86 |
| Tangible Book Valueper Share Common Eq | 377.95 | 312.75 | 259.88 |
| Total Liabilities | 53.61 | 27.3 | 25.06 |
| Total Debt | 3.11 | 0.31 | 0.85 |
| Short Term Investments | 0.2 | Not available | Not available |
| Cashand Short Term Investments | 100.82 | 68.83 | 62.15 |
| Total Receivables Net | 50.09 | 49.54 | 36.38 |
| Notes Payable/Short Term Debt | 0 | 0 | 0.06 |
| Deferred Income Tax | 6.7 | 5.82 | 4.31 |
| Accounts Receivable-Trade Net | 50.09 | 36.52 | 36.25 |
| Property/Plant/Equipment Total-Net | 27.6 | 7.22 | 7.4 |
| Minority Interest | 7.26 | 2.58 | 2.42 |
| Total Current Liabilities | 36.55 | 18.59 | 17.53 |
| Total Inventory | 18.38 | 8.74 | 8.43 |
| Accounts Payable | 6.92 | 1.97 | 3.95 |
| Other Currentliabilities Total | 29.62 | 16.62 | 13.52 |
| Total Long Term Debt | 3.11 | 0.31 | 0.79 |
| Intangibles Net | 0 | Not available | Not available |
| Other Long Term Assets Total | 0.03 | Not available | 0 |
| Note Receivable-Long Term | 0 | 0 | 0 |
| Total Current Assets | 192.66 | 132.19 | 123.4 |
| Accumulated Depreciation Total | Not available | -7.79 | -7.15 |
| Prepaid Expenses | Not available | 5.07 | Not available |
| Property/Plant/Equipment Total-Gross | Not available | 15.01 | 14.55 |
Fundamentals
Valuation and ratios
Valuation
PEG Ratio0.57
Price to Sale Ratio7.81
Growth
Debt 5Yr CAGR %9.17
Margins
Operating Margin 12m36.39
Operating Margin 5y Avg43.36
Net Profit Margin 12m42.23
Net Profit Margin 5y43.49
Yield
Dividend Yield %0.39
Risk and consensus
Source-qualified signals
Risk metrics
Overall RiskHigh risk
Board Risk53.39
Analyst consensus
Analyst consensus unavailable.
Provider consensus uses a 1 (Strong Buy) to 5 (Strong Sell) score. The payload does not include price targets, so none are inferred from 52-week prices or recommendation percentages.Industry context
Peer comparison
Only peers present in the company profile payload are displayed.
| Company | Price | Market cap | P/E | Research |
|---|---|---|---|---|
| Asian Paints | INR 2,675.55 | 2.57 L | 58.09 | — |
| Solar Industries India | INR 18,928.6 | 1.71 L | 99.61 | — |
| Pidilite Industries | INR 1,575.6 | 1.60 L | 64.76 | — |
| SRF | INR 2,860.65 | 85,038.28 | 44.57 | — |
| Linde India | INR 6,897.45 | 58,824.36 | 110.53 | — |
Shareholding
Ownership
- Promoter
- 40.95%
- FII
- 2.50%
- Other
- 56.55%
Company intelligence
Latest relevant news
Source, timestamp and external destination are shown. Provider relevance scores are not available.
ICSA India Board to Approve 4 Years of Delayed Financial Results on July 29 - WhalesbookMarket news · 20 Jul 2026, 12:48 pm
ICSA India Board to Approve 4 Years of Delayed Financial Results on July 29 Whalesbook
Enterprise value to revenue forward of 3B BlackBio Dx Ltd – NSE:3BBLACKBIO - TradingViewMarket news · 7 Jul 2026, 6:01 pm
Enterprise value to revenue forward of 3B BlackBio Dx Ltd – NSE:3BBLACKBIO TradingView
Promoter Dhirendra Dubey increases stake in 3B BlackBio Dx - scanx.tradeMarket news · 25 Jun 2026, 12:30 pm
Promoter Dhirendra Dubey increases stake in 3B BlackBio Dx scanx.trade
3B BlackBio Dx reports INR142 cr revenue, targets 15-20% growth - scanx.tradeMarket news · 3 Jun 2026, 6:48 pm
3B BlackBio Dx reports INR142 cr revenue, targets 15-20% growth scanx.trade
3B BlackBio Dx Consolidated March 2026 Net Sales at Rs 35.43 crore, up 57.52% Y-o-Y - Moneycontrol.comMarket news · 3 Jun 2026, 11:33 am
3B BlackBio Dx Consolidated March 2026 Net Sales at Rs 35.43 crore, up 57.52% Y-o-Y Moneycontrol.com
3B Blackbio DX Ltd Downgraded to Sell Amid Mixed Financial and Technical Signals - Markets MojoMarket news · 3 Jun 2026, 2:47 am
3B Blackbio DX Ltd Downgraded to Sell Amid Mixed Financial and Technical Signals Markets Mojo
Corporate actions
Events
- dividendRs.5.0000 per share(50%)Final Dividend
- board MeetingsAudited Results & Final Dividend
- board MeetingsQuarterly Results
- board MeetingsQuarterly Results
- annual General MeetingAGM
- dividendRs.4.0000 per share(40%)Dividend
- board MeetingsQuarterly Results
- board MeetingsAudited Results & Dividend
ShareKeyX Community
Discussion and sentiment for 3B Blackbio DX
Posts are linked to the canonical company record. Community BUY, NEUTRAL and SELL opinions are user-generated, moderated and separate from analyst consensus and ShareKeyX AI.
Checking your ShareKeyX account…
Company profile
Business information
What the company does
3B Blackbio DX Limited is an India-based company, which is engaged in the field of polymerase chain reaction (PCR)-based Molecular Diagnostic Kits. Its segments include Agrochemicals and Diagnostic kits. The diagnostics division of the Company is engaged in Design, Development Manufacturing and Commercialization of qPCR tests, Rapid tests, Next Gen Sequencing (NGS)-based Molecular Diagnostic Kits and Extraction Kits for reliable testing on patient samples. Its products include Oncology and Hematology, Antimicrobial Resistance, Infectious Diseases, Human Genetics, Extraction, and Rapid Antigen Kits. The PCR-based Molecular Diagnostic Kits are commercialized with TRUPCR brand to renowned diagnostics labs across the country. The Company also has a Lateral Flow Assays Vertical and a NGS Assay development division. The lateral flow assays are commercialized under the brand name TRURAPID and the NGS assays are commercialized under the brand name TRUNGS.
Company facts
- Industry
- Chemical Manufacturing
- Sector
- Chemical Manufacturing
- NSE Code
- 3BBLACKBIO
- BSE Code
- 532067
Questions
Stock FAQ
What is the symbol and ISIN of 3B Blackbio DX?
3B Blackbio DX has the symbol 3BBLACKBIO and ISIN - INE994E01018.
What is the current price of 3B Blackbio DX?
3B Blackbio DX is currently trading at INR 1,159.00.
What are the year high and year low of 3B Blackbio DX?
3B Blackbio DX has a year high of INR 1,441.50 and a year low of INR 1,085.00.
What is the market capitalization of 3B Blackbio DX?
3B Blackbio DX has a market capitalization of INR 1,107.88 crore.
What is the P/E ratio of 3B Blackbio DX?
3B Blackbio DX has a P/E ratio of 18.19.
What is the dividend yield of 3B Blackbio DX?
3B Blackbio DX has a dividend yield of 0.39%.
How is the financial performance of 3B Blackbio DX based on revenue, net income, and EPS?
3B Blackbio DX has revenue of INR 141.92 crore, net income of INR 58.59 crore, and EPS of INR 69.94.
What is the book value of 3B Blackbio DX?
3B Blackbio DX has a book value of INR 377.95.
What is the debt-to-equity ratio of 3B Blackbio DX?
3B Blackbio DX has a debt-to-equity ratio of NA.
What are the price-to-book and price-to-sales ratios of 3B Blackbio DX?
3B Blackbio DX has a price-to-book ratio of 3.07 and a price-to-sales ratio of 7.81.
Corporate-action adjustment is provider-defined. ShareKeyX research and computed indicators are not investment advice.